Jones C L, Beck L K, Brozna J P, Holley M, Dempsey E J, Kane M A
Medical Oncology Section, Denver Veterans Affairs Medical Center, Colorado 80220, USA.
Cell Growth Differ. 1995 Dec;6(12):1627-34.
Bombesin-like peptides (BLPs) activate protein kinase C (PKC), which leads to proliferation in nonmalignant Swiss 3T3 cells. The purpose of this study was to determine if PKC expression in the classic human small cell lung carcinoma NCI-H345 cell line, which has an autocrine growth loop involving BLPs, exhibited unique properties that could result in malignant behavior. PKC activity and phorbol dibutyrate binding in NCI-H345 cells had properties similar to other reports. PKC activity in the cytosolic fraction increased to 100% as cells proliferated through lag, log, and plateau growth states. However, during the first 3 days after plating (lag growth state), 40-50% of the PKC activity was membrane associated, indicating a substantial portion in an activated form, possibly a result of BLP autocrine stimulation. NCI-H345 cells expressed the PKC isoenzymes alpha, beta, delta, sigma, and eta, but not gamma or epsilon, a pattern different from Swiss 3T3 cells or normal brain. further characterization of the Ca2+/phospholipid-dependent (classic) PKC isoenzymes, alpha and beta, showed that PKC beta was predominantly cytosolic (80%) as expected, but PKC alpha was primarily membrane associated (80-90%). Exposure of NCI-H345 cells to 200 nm phorbol 12-myristyl 13-acetate rapidly (within 2 min) decreased cytosolic PKC activity, with no change in the particulate activity, but did not alter [3H]-thymidine incorporation or subcellular distribution of PKC alpha or beta by Western blot. These results suggest altered PKC regulation in human small cell lung carcinoma NCI-H345 cells, which could contribute to their malignant behavior.
蛙皮素样肽(BLPs)可激活蛋白激酶C(PKC),进而导致非恶性的瑞士3T3细胞增殖。本研究的目的是确定在具有涉及BLPs的自分泌生长环的经典人小细胞肺癌NCI-H345细胞系中,PKC表达是否表现出可能导致恶性行为的独特特性。NCI-H345细胞中的PKC活性和佛波酯二丁酸酯结合特性与其他报道相似。随着细胞通过延迟期、对数期和平稳期生长状态增殖,胞质部分的PKC活性增加至100%。然而,在接种后的前3天(延迟期生长状态),40%-50%的PKC活性与膜相关,表明相当一部分处于激活形式,这可能是BLP自分泌刺激的结果。NCI-H345细胞表达PKC同工酶α、β、δ、σ和η,但不表达γ或ε,这种模式与瑞士3T3细胞或正常脑组织不同。对Ca2+/磷脂依赖性(经典)PKC同工酶α和β的进一步表征表明,正如预期的那样,PKCβ主要位于胞质(80%),但PKCα主要与膜相关(80%-至90%)。将NCI-H345细胞暴露于200 nM佛波醇12-肉豆蔻酸酯13-乙酸酯中,可迅速(2分钟内)降低胞质PKC活性,颗粒活性无变化,但通过蛋白质印迹法未改变[3H]-胸苷掺入或PKCα或β的亚细胞分布。这些结果表明人小细胞肺癌NCI-H345细胞中PKC调节发生改变,这可能导致其恶性行为。